ImmunityBio (IBRX) stock is falling on Thursday after the company got a response letter from the FDA concerning its bladder cancer treatment. More
Articles
SoFi Technologies Stock: The Case for SOFI Hitting $10 by 2024
SOFI stock investors should be confident now as SoFi Technologies demonstrates strong revenue growth and ensures security for the depositors. More
Bloom Energy (BE) Stock Plunges on $500M Offering
Bloom Energy (BE) stock is falling on Thursday following news of the company offering $500 million in convertible senior notes. More
Why You Should Invest $100 in Lucid Group (LCID) Stock Now
Lucid Group's insistent focus on luxury over affordability makes LCID stock a hero-or-zero wager worth considering in 2023. More
TSLA Price Prediction: My Tesla Price Target for 2025
A $208 target price for TSLA stock acknowledges the growth and industry challenges in store for electric vehicle maker Tesla. More
